Changes in the urinary excretion of metabolites during treatment with nitrogen mustard and triethylenemelamine.
作者信息
GERBRANDY J, HELLENDOORN H B
出版信息
Br J Cancer. 1958 Sep;12(3):458-68. doi: 10.1038/bjc.1958.54.
Abstract
摘要
相似文献
1
Changes in the urinary excretion of metabolites during treatment with nitrogen mustard and triethylenemelamine.
Br J Cancer. 1958 Sep;12(3):458-68. doi: 10.1038/bjc.1958.54.
2
HODGKIN'S disease: diagnosis and treatment.
Med J Aust. 1953 Jun 27;1(26):934-5.
3
[Diagnosis and therapy of Hodgkin's disease; study of 110 cases].
Sem Hop. 1952 Dec 25;28(95):3855-71.
4
Treatment of Hodgkin's disease and the lymphosarcomas.
J Am Med Assoc. 1954 Jan 9;154(2):114-20. doi: 10.1001/jama.1954.02940360012004.
5
Clinical indications for the use of nitrogen mustard and triethylene melamine in malignant lymphomas and leukemias.
Ann N Y Acad Sci. 1958 Apr 24;68(3):974-8. doi: 10.1111/j.1749-6632.1958.tb42653.x.
6
Some effects of nitrogen mustard and triethylene melamine in acute disseminated lupus erythematosus.
Am J Med Sci. 1953 Aug;226(2):179-90. doi: 10.1097/00000441-195308000-00009.
7
Treatment of the leukemias and lymphomas; current trends.
J Am Med Womens Assoc. 1952 Sep;7(9):321-5.
8
[Rational approach to therapy of cancer with haloalkylamines and with ethylenemelanines].
Biull Eksp Biol Med. 1955 Sep;40(9):65-9.
9
[Triethylene melamine treatment of leukemia and lymphogranulomatosis].
Turk Tip Cemiy Mecm. 1954 Jun;20(6):290-314.
10
Mustard chemotherapy in ovarian carcinoma.
Ann Intern Med. 1959 Jun;50(6):1449-61. doi: 10.7326/0003-4819-50-6-1449.
本文引用的文献
1
The urinary excretion of metabolites during radiological cell-destruction in leukaemic patients.
Br J Cancer. 1958 Jun;12(2):275-84. doi: 10.1038/bjc.1958.33.
2
Studies on leukemia. I. Uric acid excretion.
Blood. 1956 Feb;11(2):154-66.
3
The gross electrolyte composition of certain human malignant tissues.
Cancer Res. 1955 Sep;15(8):544-9.
Zotero 插件